Thus, circPDSS1 acts as a tumor promoter by regulating miR-186-5p and NEK2, which could be a potential biomarker and therapeutic target for the management of GC.
CircRNA circPDSS1 promotes the gastric cancer progression by sponging miR-186-5p and modulating NEK2.